Balance Sheet

Current Liabilities	3.8m
Accounts Payable	1.7m
Accrued Liabilities	1.2m
Other Current Liabilities	921k
Non-Current Liabilities	223k
Other Non-Current Liabilities	223k

Currency: USD

	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	7	3	73	21	21	14	4	23	4	4
Cash Equivalents	7	3	73	21	21	14	4	23	4	4
Short-Term Investments	12	9	3	23	3	0	0	0	0	0
Total Receivables	0	1	1	4	1	0	3	3	2	2
Accounts Receivables	0	1	1	4	1	0	0	3	2	2
Other Receivables	0	0	0	0	0	0	3	0	0	0
Inventory	0	0	1	1	2	2	0	3	4	4
Other Current Assets	0	0	1	2	2	2	1	1	0	0
Total Current Assets	20	14	78	52	29	18	8	30	10	10
PP&E Net	0	0	1	1	2	2	1	2	1	0
PP&E Gross	0	0	1	1	2	2	1	2	1	0
Accumulated Depreciation	1	1	1	1	2	2	3	0	0	0
Intangible Assets	0	0	0	0	0	0	0	21	0	0
Other Long-Term Assets	0	0	0	0	0	0	1	0	0	0
Total Assets	21 N/A	14 -31%	79 +454%	53 -33%	30 -43%	20 -33%	11 -48%	53 +395%	11 -79%	11 -4%
Liabilities
Accounts Payable	0	1	1	1	1	1	1	3	2	2
Accrued Liabilities	1	3	4	6	6	3	4	3	4	1
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	0	1	0	2	10	0	0	0	0	0
Other Current Liabilities	0	2	0	1	0	0	0	1	1	1
Total Current Liabilities	1	6	5	10	17	4	5	8	7	4
Long-Term Debt	5	9	10	8	0	0	0	0	0	0
Deferred Income Tax	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	1	0	0	0	0
Total Liabilities	6 N/A	15 +155%	14 -1%	18 +24%	17 -4%	5 -74%	6 +31%	8 +38%	7 -9%	4 -47%
Equity
Common Stock	55	55	0	0	0	0	0	0	0	0
Retained Earnings	41	56	77	111	149	172	185	578	624	636
Additional Paid In Capital	1	1	141	146	162	188	189	622	628	642
Other Equity	0	0	0	0	0	0	0	0	0	0
Total Equity	15 N/A	0 N/A	64 N/A	35 -45%	13 -63%	16 +21%	5 -71%	44 +849%	4 -92%	7 +82%
Total Liabilities & Equity	21 N/A	14 -31%	79 +454%	53 -33%	30 -43%	20 -33%	11 -48%	53 +395%	11 -79%	11 -4%
Shares Outstanding
Common Shares Outstanding	0	0	0	0	0	0	0	0	1	23
Preferred Shares Outstanding	0	0	0	0	0	0	0	0	0	0

ReShape Lifesciences Inc
NASDAQ:RSLS